Silverfin false false 31/12/2023 01/01/2023 31/12/2023 Scott Barker 14/01/2020 Rachael Price 14/01/2020 21 September 2024 The principal activity of the Company during the financial year was that of orthopaedic consultancy at BMI Albyn Hospital. SC651565 2023-12-31 SC651565 bus:Director1 2023-12-31 SC651565 bus:Director2 2023-12-31 SC651565 2022-12-31 SC651565 core:CurrentFinancialInstruments 2023-12-31 SC651565 core:CurrentFinancialInstruments 2022-12-31 SC651565 core:ShareCapital 2023-12-31 SC651565 core:ShareCapital 2022-12-31 SC651565 core:RetainedEarningsAccumulatedLosses 2023-12-31 SC651565 core:RetainedEarningsAccumulatedLosses 2022-12-31 SC651565 core:OtherPropertyPlantEquipment 2022-12-31 SC651565 core:OtherPropertyPlantEquipment 2023-12-31 SC651565 bus:OrdinaryShareClass1 2023-12-31 SC651565 2023-01-01 2023-12-31 SC651565 bus:FilletedAccounts 2023-01-01 2023-12-31 SC651565 bus:SmallEntities 2023-01-01 2023-12-31 SC651565 bus:AuditExemptWithAccountantsReport 2023-01-01 2023-12-31 SC651565 bus:PrivateLimitedCompanyLtd 2023-01-01 2023-12-31 SC651565 bus:Director1 2023-01-01 2023-12-31 SC651565 bus:Director2 2023-01-01 2023-12-31 SC651565 core:OtherPropertyPlantEquipment 2023-01-01 2023-12-31 SC651565 2022-01-01 2022-12-31 SC651565 bus:OrdinaryShareClass1 2023-01-01 2023-12-31 SC651565 bus:OrdinaryShareClass1 2022-01-01 2022-12-31 SC651565 bus:OrdinaryShareClass2 2023-01-01 2023-12-31 SC651565 bus:OrdinaryShareClass2 2022-01-01 2022-12-31 iso4217:GBP xbrli:pure xbrli:shares

Company No: SC651565 (Scotland)

SCBA ORTHOPAEDICS LIMITED

UNAUDITED FINANCIAL STATEMENTS
FOR THE FINANCIAL YEAR ENDED 31 DECEMBER 2023
PAGES FOR FILING WITH THE REGISTRAR

SCBA ORTHOPAEDICS LIMITED

UNAUDITED FINANCIAL STATEMENTS

FOR THE FINANCIAL YEAR ENDED 31 DECEMBER 2023

Contents

SCBA ORTHOPAEDICS LIMITED

BALANCE SHEET

AS AT 31 DECEMBER 2023
SCBA ORTHOPAEDICS LIMITED

BALANCE SHEET (continued)

AS AT 31 DECEMBER 2023
Note 2023 2022
£ £
Fixed assets
Tangible assets 3 4,874 2,526
4,874 2,526
Current assets
Debtors 4 35,415 30,133
Cash at bank and in hand 61,062 92,246
96,477 122,379
Creditors: amounts falling due within one year 5 ( 23,194) ( 24,397)
Net current assets 73,283 97,982
Total assets less current liabilities 78,157 100,508
Provision for liabilities ( 1,034) ( 447)
Net assets 77,123 100,061
Capital and reserves
Called-up share capital 6 10 10
Profit and loss account 77,113 100,051
Total shareholders' funds 77,123 100,061

For the financial year ending 31 December 2023 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The financial statements of SCBA Orthopaedics Limited (registered number: SC651565) were approved and authorised for issue by the Board of Directors on 21 September 2024. They were signed on its behalf by:

Scott Barker
Director
SCBA ORTHOPAEDICS LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE FINANCIAL YEAR ENDED 31 DECEMBER 2023
SCBA ORTHOPAEDICS LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE FINANCIAL YEAR ENDED 31 DECEMBER 2023
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

General information and basis of accounting

SCBA Orthopaedics Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in Scotland. The address of the Company's registered office is 417 Great Western Road, Aberdeen, AB10 6NJ, Scotland, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Going concern

The directors have assessed the Balance Sheet and likely future cash flows at the date of approving these financial statements. The directors have a reasonable expectation that the Company has adequate resources to continue in operational existence and to meet its financial obligations as they fall due for at least 12 months from the date of signing these financial statements. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.

Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

Turnover is recognised when the significant risks and rewards are considered to have been transferred to the customer.

Taxation

Current tax
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Balance Sheet date.

Deferred tax
Deferred tax arises as a result of including items of income and expenditure in taxation computations in periods different from those in which they are included in the Company's financial statements. Deferred tax is provided in full on timing differences which result in an obligation to pay more or less tax at a future date, at the average tax rates that are expected to apply when the timing differences reverse, based on current tax rates and laws. Deferred tax assets and liabilities are not discounted.

The carrying amount of deferred tax assets are reviewed at each reporting date and a valuation allowance is set up against deferred tax assets so that the net carrying amount equals the highest amount that is more likely than not to be recovered based on current or future taxable profit.

Tangible fixed assets

Tangible fixed assets are stated at cost or valuation, net of depreciation and any provision for impairment. Depreciation is provided on all tangible fixed assets, other than investment property and freehold land, at rates calculated to write off the cost or valuation, less estimated residual value, of each asset on a straight-line or reducing balance basis over its expected useful life, as follows:

Plant and machinery etc. 15 % reducing balance

Residual value represents the estimated amount which would currently be obtained from disposal of an asset, after deducting estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life.

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

Leases

The Company as lessee
Assets held under finance leases, hire purchase contracts and other similar arrangements, which confer rights and obligations similar to those attached to owned assets, are capitalised as tangible fixed assets at the fair value of the leased asset (or, if lower, the present value of the minimum lease payments as determined at the inception of the lease) and are depreciated over the shorter of the lease terms and their useful lives. The capital elements of future lease obligations are recorded as liabilities, while the interest elements are charged to the Profit and Loss Account over the period of the leases to produce a constant periodic rate of interest on the remaining balance of the liability.

Rentals under operating leases are charged on a straight-line basis over the lease term, even if the payments are not made on such a basis. Benefits received and receivable as an incentive to sign an operating lease are similarly spread on a straight-line basis over the lease term.

Impairment of assets

Assets, other than those measured at fair value, are assessed for indicators of impairment at each Balance Sheet date. If there is objective evidence of impairment, an impairment loss is recognised in the Profit and Loss Account as described below.

Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand.

Trade and other creditors

Trade and other creditors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest rate method, unless the effect of discounting would be immaterial, in which case they are stated at cost.

Financial instruments

Financial assets and financial liabilities are recognised when the Company becomes a party to the contractual provisions of the instrument.

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities.

Financial assets and liabilities are only offset in the Balance Sheet when, and only when there exists a legally enforceable right to set off the recognised amounts and the Company intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.

Basic financial assets
Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs.

Basic financial liabilities
Basic financial liabilities, including creditors, are recognised at transaction price.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities.

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.

2. Employees

2023 2022
Number Number
Monthly average number of persons employed by the Company during the year, including directors 1 1

3. Tangible assets

Plant and machinery etc. Total
£ £
Cost
At 01 January 2023 3,024 3,024
Additions 3,017 3,017
At 31 December 2023 6,041 6,041
Accumulated depreciation
At 01 January 2023 498 498
Charge for the financial year 669 669
At 31 December 2023 1,167 1,167
Net book value
At 31 December 2023 4,874 4,874
At 31 December 2022 2,526 2,526

4. Debtors

2023 2022
£ £
Trade debtors 24,518 20,375
Other debtors 10,897 9,758
35,415 30,133

5. Creditors: amounts falling due within one year

2023 2022
£ £
Taxation and social security 19,568 19,947
Other creditors 3,626 4,450
23,194 24,397

6. Called-up share capital

2023 2022
£ £
Allotted, called-up and fully-paid
10 Ordinary shares of £ 1.00 each (2022: nil shares) 10 0
Nil A ordinary shares (2022: 10 shares of £ 1.00 each) 0 10
10 10